Compare TARA & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TARA | INGN |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.5M | 186.8M |
| IPO Year | N/A | 2014 |
| Metric | TARA | INGN |
|---|---|---|
| Price | $5.12 | $6.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $20.40 | $11.00 |
| AVG Volume (30 Days) | ★ 1.1M | 148.5K |
| Earning Date | 11-10-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $347,028,000.00 |
| Revenue This Year | N/A | $8.04 |
| Revenue Next Year | N/A | $8.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.68 |
| 52 Week Low | $2.77 | $5.70 |
| 52 Week High | $7.82 | $12.91 |
| Indicator | TARA | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 45.70 |
| Support Level | $5.18 | $6.53 |
| Resistance Level | $5.80 | $6.81 |
| Average True Range (ATR) | 0.27 | 0.16 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 3.90 | 47.92 |
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.